<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR66">
 <label>66.</label>
 <mixed-citation publication-type="other">Musarrat F, Chouljenko V, Dahal A, Nabi R, Chouljenko T, Jois SD, et al. The anti-HIV drug Nelfinavir Mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARS-CoV-2 Spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections. J Med Virol. 2020;10.1002/jmv.25985.</mixed-citation>
</ref>
